| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |